Medication info
Telmidrop Tablets 80 mg (Telmisartan)

Telmidrop Tablets 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
White oval tablet
Packaging
PTP - 30 tablets/box [(10 tablets/Alu-Alu × 3)], PE bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 201902497 · Approved 2019.04.23 · Insurance code 658204230

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this medicine orally once daily with water is recommended, and it may be taken regardless of meals. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of end-organ damage in high-risk diabetes
View approved original text

This medication is used to treat essential hypertension. It also helps reduce the risk of myocardial infarction, stroke, and mortality due to cardiovascular disease in patients over 55 years old who are at high risk, such as those with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attacks, or those with high-risk diabetes. It is used to improve cardiovascular health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken regardless of meals. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this medicine orally once daily with water is recommended, and it may be taken regardless of meals. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can pose serious risks, especially to the fetus and newborn, during pregnancy, so usage should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with an allergy to this drug, pregnant or breastfeeding women, patients with severe liver disease or bile duct obstruction, patients with hereditary angioedema, and patients with diabetes or severe kidney disease. Caution is advised for elderly patients, those with high serum potassium levels, patients with slightly impaired liver function, patients with valvular heart disease, patients with cardiovascular disease, those with gastrointestinal disease, and patients with renal artery stenosis. While taking this medication, side effects such as infections, hypotension, blood abnormalities, kidney dysfunction, liver dysfunction, allergic reactions, angioedema, hyperkalemia, myalgia, dyspepsia, headache, and dizziness might occur; any symptoms should prompt immediate consultation with a physician. Especially in cases of rapid blood pressure drop or symptoms of fainting or loss of consciousness, immediate treatment is required, and regular monitoring of kidney function and electrolyte levels is important. This medication may enhance the hypotensive effect or affect kidney function when taken with other antihypertensives, so consultations with healthcare professionals are necessary when combining with other medications. Women who are pregnant or planning to become pregnant should not take this medication, and it is advisable for breastfeeding women to avoid this medication as well. The safety and efficacy of this medication have not been established in children under 18 years old; therefore, it is not recommended. Overdose may result in symptoms such as hypotension, dizziness, and acute renal failure, so caution should be taken to avoid exceeding the prescribed dosage, and immediate medical attention should be sought for any abnormal symptoms. This medication should be stored in a place that is out of reach of children, not transferred to another container, and it is recommended to open the package just before use. Special caution is needed during driving or operating dangerous machinery, as blood pressure may drop suddenly.

Side effects

  • Upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
Show 106 more
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbance
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • abnormal liver function
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum and urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be safely preserved.

Appearance and packaging

Appearance

White oval tablet

Package unit

PTP - 30 tablets/box [(10 tablets/Alu-Alu × 3)], PE bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.